2021International Journal of Health SciencesOpen access

Assessment of serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients

Bela Mahajan, Jasjit Kaur Sahota, Ettishree Ettishree

Open full text 0 citations

Abstract

Background: The present study was conducted to assess serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients. Materials & Methods: 62 patients of oral squamous cell carcinoma patients of both genders were enrolled. Patients were divided into two groups. Group I had SCC patients and group II had normal subjects. In all, serum and unstimulated saliva samples obtained and subjected to assessment of lactate dehydrogenase and uric acid levels. Results: The mean serum LDH level (U/L) in group I was 342.8 and in group II was 246.0. The mean salivary LDH level (U/L) in group I was 652.8 and in group II was 248.4. The difference was significant (P< 0.05). The mean serum uric acid (mg/dl) in group I was 6.98 and in group II was 5.12. The mean salivary uric acid in group I was 5.92 and in group II was 5.26. The difference was significant (P< 0.05). Conclusion: OSCC patients had elevated level of serum and salivary LDH and uric acid.

Open-access reader

About this research paper

What this paper is about

Background: The present study was conducted to assess serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients. Materials & Methods: 62 patients of oral squamous cell carcinoma patients of both genders were enrolled. Patients were divided into two groups. Group I had SCC patients and group II had normal subjects. In all, serum and unstimulated saliva samples obtained and subjected to assessment of lactate dehydrogenase and uric acid levels. Results: The mean serum LDH level (U/L) in group I was 342.8 and in group II was 246.0. The mean salivary LDH level (U/L) in group I was 652.8 and in group II was 248.4. The difference was significant (P< 0.05). The mean serum uric acid (mg/dl) in group I was 6.98 and in group II was 5.12. The mean salivary uric acid in group I was 5.92 and in group II was 5.26. The difference was significant (P< 0.05). Conclusion: OSCC patients had elevated level of serum and salivary LDH and uric acid.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: The present study was conducted to assess serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients. Materials & Methods: 62 patients of oral squamous cell carcinoma patients of both genders were enrolled. Patients were divided into two groups. Group I had SCC patients and group II had normal subjects. In all, serum and unstimulated saliva samples obtained and subjected to assessment of lactate dehydrogenase and uric acid levels. Results: The mean serum LDH level (U/L) in group I was 342.8 and in group II was 246.0. The mean salivary LDH level (U/L) in group I was 652.8 and in group II was 248.4. The difference was significant (P< 0.05). The mean serum uric acid (mg/dl) in group I was 6.98 and in group II was 5.12. The mean salivary uric acid in group I was 5.92 and in group II was 5.26. The difference was significant (P< 0.05). Conclusion: OSCC patients had elevated level of serum and salivary LDH and uric acid.

Key concepts: Uric acid, Lactate dehydrogenase, Saliva, Basal cell, Internal medicine, Medicine, Gastroenterology, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessment of serum and salivary lactate dehydrogenase and uric acid levels in oral squamous cell carcinoma patients — Research Paper | ScholarLens